We just received data on a new analyst forecast for $KALV. Andrew Fein from HC Wainwright & Co. set a price target of 27.0 for KALV.
To track analyst ratings and price targets for $KALV, check out Quiver Quantitative's $KALV forecast page.
$KALV Price Targets
Multiple analysts have issued price targets for $KALV recently. We have seen 6 analysts offer price targets for $KALV in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Andrew Fein from HC Wainwright & Co. set a target price of $27.0 on 07/11/2025
- Jonathan Wolleben from JMP Securities set a target price of $27.0 on 07/08/2025
- Joseph Schwartz from Leerink Partners set a target price of $20.0 on 07/07/2025
- Serge Belanger from Needham set a target price of $28.0 on 04/08/2025
- Jonathan Wolleben from Citizens Capital Markets set a target price of $19.0 on 03/26/2025
- Debanjana Chatterjee from Jones Trading set a target price of $30.0 on 03/26/2025
$KALV Insider Trading Activity
$KALV insiders have traded $KALV stock on the open market 26 times in the past 6 months. Of those trades, 9 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $KALV stock by insiders over the last 6 months:
- HEALTHCARE CAPITAL PARTNERS III, L.P. VENROCK has made 9 purchases buying 361,212 shares for an estimated $3,322,933 and 0 sales.
- BENJAMIN L PALLEIKO (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 6 sales selling 65,728 shares for an estimated $915,284.
- CHRISTOPHER YEA (CHIEF DEVELOPMENT OFFICER) has made 0 purchases and 6 sales selling 41,612 shares for an estimated $599,557.
- PAUL K. AUDHYA (CHIEF MEDICAL OFFICER) has made 0 purchases and 5 sales selling 13,130 shares for an estimated $143,769.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KALV Hedge Fund Activity
We have seen 65 institutional investors add shares of $KALV stock to their portfolio, and 58 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BOXER CAPITAL MANAGEMENT, LLC removed 1,590,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $18,348,600
- SILVERARC CAPITAL MANAGEMENT, LLC added 1,086,811 shares (+177.5%) to their portfolio in Q1 2025, for an estimated $12,541,798
- GREAT POINT PARTNERS LLC removed 772,636 shares (-43.2%) from their portfolio in Q1 2025, for an estimated $8,916,219
- PARKMAN HEALTHCARE PARTNERS LLC added 753,752 shares (+inf%) to their portfolio in Q1 2025, for an estimated $8,698,298
- STEMPOINT CAPITAL LP removed 605,966 shares (-61.0%) from their portfolio in Q1 2025, for an estimated $6,992,847
- SCHONFELD STRATEGIC ADVISORS LLC added 581,746 shares (+inf%) to their portfolio in Q1 2025, for an estimated $6,713,348
- VR ADVISER, LLC added 454,254 shares (+7.3%) to their portfolio in Q1 2025, for an estimated $5,242,091
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
